| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 00:00 | 20 Jun | 82.15 |
0.30 (0.37%) |
OPEN
85.75 |
HIGH
85.75 |
LOW
81.20 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 85.75 |
| PREVIOUS CLOSE | 81.85 |
| VOLUME | 921 |
| 52-Week high | 112.85 |
| 52-Week low | 53.10 |
| P/E | 14.49 |
| Mkt Cap.(Rs cr) | 51 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API's), Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai, with a manufacturing facility located at Tarapur, 120 Km from Mumbai. Since inception, the company has focused on providing quality pharmaceuticals while maintaining high manufacturing standards. The company's...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Sharat Deorah | ||||||
| Whole-time Director : | Siddhartha Deorah | ||||||
| Director : | Goverdhandas Aggarwal | ||||||
| Director : | Kailash Chandra Bubna | ||||||
| Director : | Kavita Vijayakant Sharma | ||||||
| Company Secretary : | Shanu Patania | ||||||
| AUDITOR : | Khurdia Jain & Co/Kothari Jain & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| K-56 MIDC Indl Area, Tarapur Boisar,Thane,Maharashtra-401506 | |||||||
| Ph : 91-22-66635456 | |||||||
| WEBSITE : http://www.aurolabs.com | |||||||
| E-mail : auro@aurolabs.com | |||||||
